Loading
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Jun 2012 for KENSEY NASH CORP, €244.0M.
Insider track record
Disclosed buys
5
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
5
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Royal DSM N.V.: trading record in brief
This profile gathers the share dealings of Royal DSM N.V. across 2 companies, led by Martek Biosciences Corp and Kensey Nash Corp. In total, 5 filings cover trades dated from 22 February 2011 to 22 June 2012.
The open-market record is one-sided, with 5 purchases worth €611.7M and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2012: 1 purchase and no sales on the market.
A typical purchase (the median) is worth €5.6M.
The record was last updated on 25 June 2012 with an open-market purchase (€244.0M) in Kensey Nash Corp. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Royal DSM N.V.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
7,953,922 shares@ US$38.50Common StockSEC:0001104659-12-045611:0
Canonical exit: 20 Sept 2012 (T+90)
15,712,946 shares@ US$31.50Common StockSEC:0001104659-11-011541:0
Canonical exit: 23 May 2011 (T+90)
32 shares@ US$31.50Common StockSEC:0001104659-11-009912:0
Canonical exit: 23 May 2011 (T+90)
17,000 shares@ US$31.50Common StockSEC:0001104659-11-009912:1
Canonical exit: 24 May 2011 (T+90)
245,302 shares@ US$31.50Common StockSEC:0001104659-11-009912:2
Canonical exit: 25 May 2011 (T+90)
5 of 5 declarations
